217 related articles for article (PubMed ID: 21166664)
1. Bath psoralen plus ultraviolet A for hidradenitis suppurativa: a review of 13 patients.
Shareef M; Dawe R
Br J Dermatol; 2011 Apr; 164(4):895-6. PubMed ID: 21166664
[No Abstract] [Full Text] [Related]
2. An evaluation of the preferences of patients with psoriasis between systemic psoralen plus ultraviolet A and bath psoralen plus ultraviolet A.
Alshiyab D; Chin MF; Edwards C; Anstey AV
Br J Dermatol; 2015; 172(5):1457-8. PubMed ID: 25420468
[No Abstract] [Full Text] [Related]
3. Treatment of cutaneous sarcoid with topical gel psoralen and ultraviolet A.
Gleeson CM; Morar N; Staveley I; Bunker CB
Br J Dermatol; 2011 Apr; 164(4):892-4. PubMed ID: 21143466
[No Abstract] [Full Text] [Related]
4. Treatment of plaque-type localized scleroderma with retinoic acid and ultraviolet A plus the photosensitizer psoralen: a case series.
Ozdemir M; Engin B; Toy H; Mevlitoglu I
J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):519-21. PubMed ID: 18363929
[No Abstract] [Full Text] [Related]
5. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
Bhatnagar A; Kanwar AJ; Parsad D; De D
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
[TBL] [Abstract][Full Text] [Related]
6. Role of bath psoralen plus ultraviolet A in early-stage mycosis fungoides.
Pavlotsky F; Hodak E; Ben Amitay D; Barzilai A
J Am Acad Dermatol; 2014 Sep; 71(3):536-41. PubMed ID: 24836546
[TBL] [Abstract][Full Text] [Related]
7. Randomized, double-blind, placebo-controlled evaluation of the efficacy of oral psoralen plus ultraviolet A for the treatment of plaque-type psoriasis using the Psoriasis Area Severity Index score (improvement of 75% or greater) at 12 weeks.
Sivanesan SP; Gattu S; Hong J; Chavez-Frazier A; Bandow GD; Malick F; Kricorian G; Koo J
J Am Acad Dermatol; 2009 Nov; 61(5):793-8. PubMed ID: 19766350
[TBL] [Abstract][Full Text] [Related]
8. Psoralen plus long-wave UV-A (PUVA) and bexarotene therapy: An effective and synergistic combined adjunct to therapy for patients with advanced cutaneous T-cell lymphoma.
McGinnis KS; Shapiro M; Vittorio CC; Rook AH; Junkins-Hopkins JM
Arch Dermatol; 2003 Jun; 139(6):771-5. PubMed ID: 12810509
[TBL] [Abstract][Full Text] [Related]
9. Psoralen plus ultraviolet A light phototherapy effectiveness.
Feldman SR
J Am Acad Dermatol; 2010 Oct; 63(4):718. PubMed ID: 20846573
[No Abstract] [Full Text] [Related]
10. Bath psoralen+ultraviolet A photochemotherapy vs. narrow band-ultraviolet B in psoriasis: a comparison of clinical outcome and effect on circulating T-helper and T-suppressor/cytotoxic cells.
Salem SA; Barakat MA; Morcos CM
Photodermatol Photoimmunol Photomed; 2010 Oct; 26(5):235-42. PubMed ID: 20831697
[TBL] [Abstract][Full Text] [Related]
11. Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial.
Grant A; Gonzalez T; Montgomery MO; Cardenas V; Kerdel FA
J Am Acad Dermatol; 2010 Feb; 62(2):205-17. PubMed ID: 20115947
[TBL] [Abstract][Full Text] [Related]
12. Psoralen and ultraviolet a light therapy for psoriasis.
Stern RS
N Engl J Med; 2007 Aug; 357(7):682-90. PubMed ID: 17699818
[No Abstract] [Full Text] [Related]
13. Photo(chemo)therapy for vitiligo.
Pacifico A; Leone G
Photodermatol Photoimmunol Photomed; 2011 Oct; 27(5):261-77. PubMed ID: 21950634
[TBL] [Abstract][Full Text] [Related]
14. PUVA-gel vs. PUVA-bath therapy for severe recalcitrant palmoplantar dermatoses. A randomized, single-blinded prospective study.
Schiener R; Gottlöber P; Müller B; Williams S; Pillekamp H; Peter RU; Kerscher M
Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):62-7. PubMed ID: 15752122
[TBL] [Abstract][Full Text] [Related]
15. Randomized controlled observer-blinded treatment of chronic foot eczema with iontophoresis and bath-PUVA.
Tupker RA; Coenraads PJ; Zanen P; Schuttelaar ML
Acta Derm Venereol; 2013 Jul; 93(4):456-60. PubMed ID: 23420314
[TBL] [Abstract][Full Text] [Related]
16. Bath-PUVA therapy improves impaired resting regulatory T cells and increases activated regulatory T cells in psoriasis.
Kubo R; Muramatsu S; Sagawa Y; Saito C; Kasuya S; Nishioka A; Nishida E; Yamazaki S; Morita A
J Dermatol Sci; 2017 Apr; 86(1):46-53. PubMed ID: 28139335
[TBL] [Abstract][Full Text] [Related]
17. Psoralen plus UVA vs. UVB-311 nm for the treatment of lichen planus.
Wackernagel A; Legat FJ; Hofer A; Quehenberger F; Kerl H; Wolf P
Photodermatol Photoimmunol Photomed; 2007 Feb; 23(1):15-9. PubMed ID: 17254030
[TBL] [Abstract][Full Text] [Related]
18. Treatment of recalcitrant hidradenitis suppurativa with photodynamic therapy: report of five cases.
Sotiriou E; Apalla Z; Maliamani F; Ioannides D
Clin Exp Dermatol; 2009 Oct; 34(7):e235-6. PubMed ID: 19508581
[No Abstract] [Full Text] [Related]
19. Randomized double-blind trial of the treatment of chronic plaque psoriasis: efficacy of psoralen-UV-A therapy vs narrowband UV-B therapy.
Yones SS; Palmer RA; Garibaldinos TT; Hawk JL
Arch Dermatol; 2006 Jul; 142(7):836-42. PubMed ID: 16847198
[TBL] [Abstract][Full Text] [Related]
20. Two cases of cutaneous chronic graft versus host disease in treatment with psoralen plus ultraviolet-A-bath photochemotherapy.
Hoffner MV; Carrizosa Esquivel A; Pulpillo Ruiz A; Herrera Saval A; Conejo-Mir J; Camacho FM
J Drugs Dermatol; 2009 Nov; 8(11):1027-9. PubMed ID: 19894371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
